Development of cross-resistance to tamoxifen in raloxifene-treated breast carcinoma cells. [electronic resource]
- Anticancer research
- 1379-83 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0250-7005
Antineoplastic Agents, Hormonal--pharmacology Breast Neoplasms--drug therapy Cell Division--drug effects Dose-Response Relationship, Drug Drug Resistance, Multiple Drug Resistance, Neoplasm Humans Inhibitory Concentration 50 Raloxifene Hydrochloride--pharmacology Selective Estrogen Receptor Modulators--pharmacology Tamoxifen--pharmacology Tumor Cells, Cultured